Lanalget Retard (Tramadol Hydrochloride)

Tramadol acts centrally by weakly stimulating μ‑opioid receptors and by blocking the reuptake of serotonin and norepinephrine. This combined effect enhances the body’s natural pain‑inhibiting pathways, reducing the perception of pain.

The appropriate dose of Lanalget Retard is determined by the prescribing clinician based on the patient’s pain severity, medical history, and response to therapy. Dosage adjustments may be needed for renal or hepatic impairment.

Safety data for tramadol in pregnancy and lactation are limited. It should only be used when the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To request Lanalget Retard, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with stronger opioids, tramadol offers a milder μ‑opioid effect and adds serotonergic and noradrenergic activity, which may provide broader pain relief with a different side‑effect profile. It is often chosen when a balance between efficacy and lower risk of respiratory depression is desired.

Lanalget Retard should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the tablets from moisture, heat and direct sunlight to maintain potency and stability.

Lanalget Retard is taken orally, usually with a full glass of water. It may be taken with or without food, but consistent administration with respect to meals can help reduce gastrointestinal discomfort.

Serious risks include respiratory depression, seizures, serotonin syndrome (especially when combined with serotonergic drugs), severe allergic reactions, and the potential for dependence or abuse. Patients should be monitored closely for these events, particularly during dose escalation.

Lanalget Retard is contraindicated in patients with known hypersensitivity to tramadol, those taking monoamine oxidase inhibitors, or individuals with uncontrolled epilepsy. Caution is also advised for patients with severe respiratory disorders, severe hepatic or renal impairment, and in the elderly.